A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
IDEAYA Biosciences
Azienda Ospedaliero-Universitaria di Parma
A2 Biotherapeutics Inc.
Nurix Therapeutics, Inc.
Medicenna Therapeutics, Inc.
Cancer Research UK
Novartis
University Hospital, Antwerp